In this episode, W. Clay Jackson, MD, DipTH, speaks about the differences between schizophrenia and dissociative identity disorder, how patients with schizophrenia should be managed, and the gaps in the...
In this Q&A, W. Clay Jackson, MD, DipTH, speaks about various aspects of schizophrenia, including the symptoms, risk factors, and associated controversies surrounding these risk factors.
In this Q&A, W. Clay Jackson, MD, answers questions about the positive and negative symptoms, the therapeutic challenges, the gold standard of treatment of patients with schizophrenia, and some...
In part 1 of this podcast series, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA, discusses the 5 criteria used to help diagnose schizophrenia, as well as the differential...
Dr Laitman discusses evidence supporting the reclassification of schizophrenia as a neurological disorder, his views on how reclassification could impact prognosis and recovery, and treatment interventions...
In the final installment of this podcast series, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA discusses suicidality in patients with schizophrenia compared with the general...
In part 3 of his podcast series with Consultant360, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA explains the importance of treating his patients’ physical and societal health in...
Schizophrenia is not a death sentence, says Robert S Laitman, MD, from Bronx Westchester Medical Group and SARDAA. In part 2 of his podcast series with Consultant360, Dr Laitman explains how his approach to...
Dr Raymond Cho, from Baylor College of Medicine, discusses the upcoming SARDAA conference on schizophrenia and his outlook on mental health in the United States.
Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA, discusses his session at SARDAA's conference as well as overcoming the mental health stigma in the United States.
